AU5136693A - Antisense oligonucleotides to b myb proto-oncogene - Google Patents

Antisense oligonucleotides to b myb proto-oncogene

Info

Publication number
AU5136693A
AU5136693A AU51366/93A AU5136693A AU5136693A AU 5136693 A AU5136693 A AU 5136693A AU 51366/93 A AU51366/93 A AU 51366/93A AU 5136693 A AU5136693 A AU 5136693A AU 5136693 A AU5136693 A AU 5136693A
Authority
AU
Australia
Prior art keywords
oncogene
antisense oligonucleotides
myb proto
myb
proto
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51366/93A
Inventor
Bruno Calabretta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thomas Jefferson University
Original Assignee
Thomas Jefferson University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Jefferson University filed Critical Thomas Jefferson University
Publication of AU5136693A publication Critical patent/AU5136693A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU51366/93A 1992-10-01 1993-09-23 Antisense oligonucleotides to b myb proto-oncogene Abandoned AU5136693A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95669892A 1992-10-01 1992-10-01
US956698 1992-10-01
PCT/US1993/009013 WO1994007538A1 (en) 1992-10-01 1993-09-23 ANTISENSE OLIGONUCLEOTIDES TO B-m^_y^_b^_ PROTO-ONCOGENE

Publications (1)

Publication Number Publication Date
AU5136693A true AU5136693A (en) 1994-04-26

Family

ID=25498565

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51366/93A Abandoned AU5136693A (en) 1992-10-01 1993-09-23 Antisense oligonucleotides to b myb proto-oncogene

Country Status (2)

Country Link
AU (1) AU5136693A (en)
WO (1) WO1994007538A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3217599A (en) 1998-03-31 1999-10-18 Genzyme Corporation Methods for the diagnosis and treatment of lung cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098890A (en) * 1988-11-07 1992-03-24 Temple University-Of The Commonwealth System Of Higher Education Antisence oligonucleotides to c-myb proto-oncogene and uses thereof
US5087617A (en) * 1989-02-15 1992-02-11 Board Of Regents, The University Of Texas System Methods and compositions for treatment of cancer using oligonucleotides

Also Published As

Publication number Publication date
WO1994007538A1 (en) 1994-04-14

Similar Documents

Publication Publication Date Title
IL105824A0 (en) Single use intrauterine injector
AU5568694A (en) Stable oligonucleotides
AU4743093A (en) Antisense polynucleotides
GB2265069B (en) Improvements in or relating to networks
AU5162993A (en) Siloxy oligonucleotide analogs
EP0567918A3 (en) Azopigment preparation
GB2264216B (en) Multi-share plough
GB9225925D0 (en) Improvements relating to cylinders
GB9213207D0 (en) Improvements relating to communication system
AU5136693A (en) Antisense oligonucleotides to b myb proto-oncogene
AU5086393A (en) Antisense oligonucleotides to cyclin d1 proto-oncogene
GB2272770B (en) Improvements to electrocardiagraphs
GB9218718D0 (en) Improvements relating to carrings
EP0580795A4 (en) Antisense oligonucleotides to c-kit proto-oncogene and uses thereof
AU4510093A (en) Improvements relating to locks
AU2387292A (en) Antisense oligonucleotides
GB9315948D0 (en) Implement
GB9216105D0 (en) Improvements relating to wheelchairs
GB9219302D0 (en) Improvements relating to syringe
GB2264634B (en) Improvements relating to racking
GB9317278D0 (en) Improvements relating to ploughs
GB9207413D0 (en) Improvements relating to playballs
GB9217385D0 (en) Improvements relating to coathangers
GB9213278D0 (en) Improvements relating to playballs
GB9219183D0 (en) Improvements relating to headdresses